Genetic editing creates a distinct human subspecies before 2050.

Question

Six frontier AI models put this at 3% by 6 Oct 2076. Full reasoning from every model.

WillHappen.ai · Accepted Answer

3% — the median of 6 frontier models, resolving by 2076-10-06.

Answer

Gemini (Google): 2% — Speciation requires reproductive isolation across generations, which twenty-four years of human life cycles cannot accommodate. Establishing a distinct subspecies by 2050 requires multiple generations of an isolated, edited breeding pool that does not intermate. Global bans under the Oviedo Convention and UNESCO norms make open state-sponsored germline divergence politically impossible. Illicit edits will yield isolated somatic or germline variants, but taxonomic bodies will not classify them as a new subspecies.

Answer

Claude (Anthropic): 2% — No scientific or political body is close to recognizing a 'distinct human subspecies' via editing. Germline editing is still banned or heavily restricted in nearly all countries, with only isolated rogue cases like He Jiankui's 2018 babies. Creating a self-sustaining, reproductively distinct population requires generations of controlled breeding plus formal taxonomic/scientific recognition, which has no… Social, ethical, and regulatory resistance remains extremely high, and even optimistic biotech timelines don't envision population-level divergence by 2050.

Answer

GPT (OpenAI): 17% — It turns on whether heritable editing becomes widespread enough to form an isolated, officially recognized lineage. A viable edited population requires regulators, clinics, parents, and likely multiple states to permit germline use over decades. Human subspecies recognition needs durable genetic differentiation and reproductive or social separation, not a few edited births. The 2018 He Jiankui case triggered broad condemnation; permissive regimes or safe polygenic editing would raise the odds most.

Answer

Grok (xAI): 3% — Whether edited humans form a recognized, multi-generation population with diagnostic alleles by 2050. IUBS/IUCN have never split H. sapiens; subspecies status needs decades of papers plus heritable divergence. Germline editing stays banned or tiny-scale after He Jiankui; even a 2035 cohort yields only one generation by 2050. A crash unregulated program producing thousands of non-mixing descendants with unique alleles by 2040 would shift this.

Answer

DeepSeek (DeepSeek): 3% — No institution will certify a separate human subspecies; heritable edits stay banned and too rare to found a population. The 2023 Third International Summit on Human Genome Editing reaffirmed no heritable germline editing, and 70+ countries ban it, so no legal pathway exists. Even rogue work like He Jiankui's 2018 twins produced no viable lineage, and no regulator has ever recognized a human subspecies category. By 2076, somatic editing will be routine but heritable edits remain fringe; recognition would require a scientific body to define and certify a population, which no one…

Answer

Qwen (Alibaba): 1% — Requires both a large edited population and formal subspecies recognition—neither is remotely plausible by 2050. No heritable genome editing is legally permitted anywhere; the WHO moratorium and national bans show no signs of lifting before 2035 at earliest. Even with immediate legalization, only 1–2 generations could exist by 2050—far too few individuals and too little divergence for any taxonomic body to recognize a… No human subspecies has ever been formally designated in modern biology; the concept itself is rejected by most geneticists, making recognition nearly impossible…

Genetic editing creates a distinct human subspecies before 2050.

Cedars-Sinai reports that microgravity improved the production of stem-cell-derived structures from the CRS-35 mission experiments.

A human life expectancy surpasses 150 years through medical intervention before 2050.

Mount Sinai's CRS-35 tissue model experiment yields publishable data on microgravity-induced aging or functional changes.

A therapeutic treatment scientifically proven to reverse cellular aging in humans receives regulatory approval before 2035.